WrapManager Inc’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,408
Closed -$293K 231
2024
Q4
$293K Sell
7,408
-2,250
-23% -$85.2K 0.08% 163
2024
Q3
$329K Sell
9,658
-8,252
-46% -$232K 0.09% 159
2024
Q2
$388K Buy
17,910
+1,684
+10% +$35.4K 0.11% 147
2024
Q1
$360K Buy
16,226
+4,500
+38% +$110K 0.1% 176
2023
Q4
$323K Buy
11,726
+2,617
+29% +$63.2K 0.09% 194
2023
Q3
$203K Sell
9,109
-388
-4% -$9.98K 0.07% 262
2023
Q2
$242K Sell
9,497
-377
-4% -$9.14K 0.07% 243
2023
Q1
$220K Buy
+9,874
New +$239K 0.07% 249
2022
Q4
Sell
-13,210
Closed -$219K 300
2022
Q3
$219K Sell
13,210
-826
-6% -$18.6K 0.07% 240
2022
Q2
$279K Buy
14,036
+1,321
+10% +$26.7K 0.09% 228
2022
Q1
$351K Buy
12,715
+3,941
+45% +$113K 0.09% 208
2021
Q4
$361K Sell
8,774
-501
-5% -$22.1K 0.09% 211
2021
Q3
$431K Buy
+9,275
New +$405K 0.11% 177

Other funds holding VCYT

WrapManager Inc's VCYT Position: Q1 2025 in Review

WrapManager Inc sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 7,408 shares — an estimated $293K sold.

WrapManager Inc first reported a position in VCYT in Q3 2021 and held it in 13 quarters. The position peaked at $431K in Q3 2021. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • WrapManager Inc reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • WrapManager Inc sold 7,408 Veracyte shares in Q1 2025, an estimated $293K.
  • WrapManager Inc first reported a position in Veracyte in Q3 2021 and held it in 13 quarters.
  • WrapManager Inc's Veracyte position peaked at $431K in Q3 2021.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on WrapManager Inc's 13F filing for Q1 2025, filed 8 May 2025.